ABSTRACT
For over three decades inhaled corticosteroids (ICS) have been the most
effective disease-modifying therapy available in the management of adult
asthma and have represented the mainstay of long-term asthma treatment.
This chapter reviews the clinical issues, which are relevant to their optimal use in individual patients with asthma, as well as the public health issues
relating to population-based prescribing.
